X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4029) 4029
Publication (31) 31
Book Chapter (24) 24
Dissertation (11) 11
Book / eBook (1) 1
Conference Proceeding (1) 1
Magazine Article (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
preserved ejection fraction (2736) 2736
cardiac & cardiovascular systems (2445) 2445
humans (2313) 2313
heart failure (2132) 2132
male (1364) 1364
female (1317) 1317
heart failure with preserved ejection fraction (1087) 1087
aged (1063) 1063
heart failure - physiopathology (948) 948
middle aged (870) 870
echocardiography (840) 840
mortality (824) 824
prognosis (735) 735
heart-failure (722) 722
hypertension (597) 597
stroke volume (585) 585
risk factors (579) 579
diagnosis (542) 542
cardiovascular (524) 524
dysfunction (512) 512
diastolic dysfunction (506) 506
cardiology (443) 443
stroke volume - physiology (434) 434
heart failure - diagnosis (431) 431
aged, 80 and over (421) 421
prevalence (414) 414
abridged index medicus (411) 411
heart (411) 411
heart diseases (379) 379
outcomes (371) 371
analysis (361) 361
cardiac patients (355) 355
animals (348) 348
heart failure - drug therapy (348) 348
peripheral vascular disease (347) 347
association (336) 336
exercise (333) 333
care and treatment (329) 329
prospective studies (311) 311
heart failure - mortality (303) 303
treatment outcome (300) 300
cardiovascular disease (285) 285
diastolic function (281) 281
heart failure - therapy (281) 281
ejection fraction (268) 268
pulmonary hypertension (268) 268
blood pressure (266) 266
exercise capacity (266) 266
diastole (263) 263
ventricular dysfunction, left - physiopathology (260) 260
risk (258) 258
ventricular function, left (258) 258
heart failure - epidemiology (254) 254
adult (253) 253
medicine, general & internal (252) 252
hemodynamics (251) 251
disease (248) 248
medicine & public health (243) 243
follow-up studies (239) 239
systolic function (229) 229
epidemiology (226) 226
research (226) 226
management (216) 216
guidelines (212) 212
health aspects (211) 211
patients (210) 210
hospitalization (209) 209
european-society (206) 206
myocardial-infarction (202) 202
retrospective studies (202) 202
ventricular function, left - physiology (201) 201
internal medicine (198) 198
fibrosis (197) 197
heart failure - complications (197) 197
survival (193) 193
diabetes (191) 191
recommendations (189) 189
comorbidity (187) 187
population (186) 186
physiology (185) 185
time factors (185) 185
biomarkers (180) 180
ventricle (180) 180
double-blind (176) 176
biomarkers - blood (174) 174
left-ventricular dysfunction (170) 170
heart failure - diagnostic imaging (168) 168
heart failure - blood (167) 167
atrial fibrillation (166) 166
predictive value of tests (166) 166
natriuretic peptide (165) 165
prognostic value (165) 165
natriuretic peptides (164) 164
cardiovascular diseases (163) 163
task-force (162) 162
trial (162) 162
spironolactone (161) 161
community (159) 159
medical research (158) 158
pharmacology & pharmacy (158) 158
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3942) 3942
German (48) 48
Russian (47) 47
Spanish (35) 35
Portuguese (16) 16
Japanese (15) 15
French (14) 14
Czech (9) 9
Polish (4) 4
Turkish (3) 3
Korean (2) 2
Slovak (2) 2
Chinese (1) 1
Hungarian (1) 1
Icelandic (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 12/2014, Volume 130, Issue 25, pp. 2310 - 2320
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2010, Volume 55, Issue 6, pp. 526 - 537
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 10/2017, Volume 10, Issue 10, pp. 1211 - 1221
...) stratify clinical phenotypes and outcome in heart failure preserved ejection fraction (HFpEF) patients. Background Pulmonary hypertension and RV dysfunction are key hemodynamic abnormalities in HFpEF... 
heart failure with preserved ejection fraction | right ventricle | pulmonary hypertension | hemodynamics | CARDIAC & CARDIOVASCULAR SYSTEMS | ASSOCIATIONS | CARDIOLOGY | PLANE SYSTOLIC EXCURSION | EUROPEAN-SOCIETY | COMMUNITY | RECOMMENDATIONS | RIGHT-VENTRICULAR FUNCTION | ECHOCARDIOGRAPHY | DYSFUNCTION | HYPERTENSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Predictive Value of Tests | Hypertension, Pulmonary - diagnosis | Prevalence | Prognosis | Prospective Studies | Humans | Middle Aged | Heart Failure - physiopathology | Ventricular Dysfunction, Right - epidemiology | Hypertension, Pulmonary - physiopathology | Male | Cardiac Catheterization | Arterial Pressure | Echocardiography, Doppler | Aged, 80 and over | Female | Ventricular Dysfunction, Right - physiopathology | Heart Failure - diagnosis | Chicago - epidemiology | Heart Failure - epidemiology | Myocardial Contraction | Severity of Illness Index | Reproducibility of Results | Comorbidity | Risk Factors | Pulmonary Artery - physiopathology | Hypertension, Pulmonary - epidemiology | Ventricular Dysfunction, Right - diagnosis | Pulmonary Circulation | Stroke Volume | Phenotype | Italy - epidemiology | Aged | Ventricular Function, Right | Heart failure | Atrial fibrillation | Patient outcomes | Risk factors | Pulmonary hypertension
Journal Article
Circulation: Heart Failure, ISSN 1941-3289, 11/2012, Volume 5, Issue 6, pp. 710 - 719
Journal Article
European heart journal, ISSN 1522-9645, 2010, Volume 32, Issue 6, pp. 670 - 679
Journal Article
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2015, Volume 132, Issue 5, pp. 402 - 414
...) with preserved ejection fraction (HFpEF), but its prognostic relevance is not known. We determined whether left ventricular longitudinal strain (LS... 
clinical trial | strain | heart failure | heart ventricles | spironolactone | preserved left ventricular function | CARDIAC-FUNCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | TOPCAT TRIAL | ALDOSTERONE ANTAGONIST TRIAL | MYOCARDIAL DEFORMATION | RANDOMIZED CONTROLLED-TRIAL | EUROPEAN-SOCIETY | DIASTOLIC DYSFUNCTION | SOCIETY-OF-CARDIOLOGY | SPECKLE TRACKING ECHOCARDIOGRAPHY | PERIPHERAL VASCULAR DISEASE | AMERICAN-SOCIETY | Prognosis | Follow-Up Studies | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Ventricular Dysfunction, Left - mortality | Incidence | Spironolactone - pharmacology | Mineralocorticoid Receptor Antagonists - pharmacology | Aged, 80 and over | Electrocardiography | Female | Spironolactone - therapeutic use | Double-Blind Method | Heart Failure, Systolic - drug therapy | Heart Failure, Systolic - mortality | Heart Arrest - epidemiology | Stroke Volume - physiology | Stroke Volume - drug effects | Survival Rate | Treatment Outcome | Ventricular Dysfunction, Left - physiopathology | Mineralocorticoid Receptor Antagonists - therapeutic use | Ventricular Dysfunction, Left - drug therapy | Internationality | Heart Failure, Systolic - physiopathology | Aged | Heart failure | Usage | Echocardiography | Research | Heart ventricles | Risk factors | Heart failure with preserved ejection fraction | systolic function | clinical trials | echocardiography
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2009, Volume 53, Issue 23, pp. 2150 - 2158
Journal Article